Register
SEC Form 4 insider trading filings tracked in real time from EDGAR

Sullivan Christopher Ryan — Chief Financial Officer

Insider trading activity for Sullivan Christopher Ryan sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: Avalo Therapeutics, Inc.
  • Total insider trades: 28
  • Total buy volume: $82K
  • Total sell volume: $2.3M
  • Last trade: Sep 18, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Sep 16, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 12,394 N/A
Sep 16, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 12,394 $202K
Sep 16, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 12,394 $122K
Sep 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 10,185 N/A
Sep 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 10,185 $179K
Sep 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 10,185 $82K
Sep 10, 2026 Sullivan Christopher Ryan AAVTX Avalo Therapeutics, Inc. BUY 10,185 $82K
Jun 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 138 $2K
May 21, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 39,900 N/A
May 7, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 18,606 N/A
May 7, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 18,606 $449K
May 7, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 18,606 $184K
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 47,000 N/A
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 8,900 $201K
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 9,219 $197K
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 2,700 $56K
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 12,347 $238K
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 13,834 $257K
May 6, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 47,000 $378K
Apr 30, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 8,457 $112K

← All executives · Full trades feed